Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3.

P-Glycoproteins (P-gps) are membrane glycoproteins encoded by the mdr gene family, and their overexpression is associated with multidrug resistance (MDR). Sequence analyses of mdr cDNAs predict a protein formed by two symmetrical halves, each composed of six transmembrane (TM) segments and one ATP-binding domain. To determine the topology of the N-terminal half of P-gp, a small antigenic peptide epitope (YPYDVPDYAIEGR) containing part of the hemagglutinin (HA) of influenza virus was inserted at six different positions of the Mdr3 protein (101, 161, 206, 244, 320, and 376). Functional integrity of the modified proteins was tested by measuring their capacity to confer MDR in Chinese hamster ovary cells. Intracellular and extracellular localization of the tag in the full-length protein was determined in intact or permeabilized cells by immunofluorescence using a mouse monoclonal antibody (12CA5) specific for the HA epitope. While insertions at positions 101, 161, 320, and 376 did not alter P-gp function, insertions at positions 206 and 244 abrogated the capacity of P-gp to confer drug resistance. The epitope tags inserted at positions 161 and 376 were found to be located intracellularly, whereas the tags at positions 101 and 320 were located on the extracellular side of the membrane. These results indicate that the intervening segments separating predicted TM1-TM2 and TM5-TM6 correspond to extracellular regions, while the segments linking TM2-TM3 and the one located downstream of TM6 correspond to intracellular regions. These results are consistent with a six TM domain model for the N-terminal half of P-gp with an extracellular glycosylated region (TM1-TM2) and an intracellular ATP-binding site (downstream TM6). Epitope insertion in segments linking TM3-TM4 and TM4-TM5 caused a loss of P-gp function, suggesting that the integrity of these sequences is essential either for drug transport or for proper maturation and accurate targeting of P-gp to the plasma membrane.

[1]  O. Béjà,et al.  Membrane topology of multidrug resistance protein expressed in Escherichia coli. N-terminal domain. , 1994, The Journal of biological chemistry.

[2]  T. Jensen,et al.  Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion. , 1994, The Journal of biological chemistry.

[3]  V. Lingappa,et al.  Transmembrane orientation and topogenesis of the third and fourth membrane-spanning regions of human P-glycoprotein (MDR1). , 1994, Cancer research.

[4]  P. Gros,et al.  Functional expression of P-glycoproteins in secretory vesicles. , 1994, The Journal of biological chemistry.

[5]  V. Ling,et al.  ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.

[6]  V. Canfield,et al.  Transmembrane organization of the Na,K-ATPase determined by epitope addition. , 1993, Biochemistry.

[7]  V. Lingappa,et al.  Amino-terminal assembly of human P-glycoprotein at the endoplasmic reticulum is directed by cooperative actions of two internal sequences. , 1993, The Journal of biological chemistry.

[8]  P. Roepe,et al.  Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein. , 1993, Biochemistry.

[9]  B. Persson,et al.  Properties and purification of an active biotinylated lactose permease from Escherichia coli. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Ling,et al.  Membrane topology of the N-terminal half of the hamster P-glycoprotein molecule. , 1993, The Journal of biological chemistry.

[11]  A. Brossi,et al.  The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance. , 1993, Biochemistry.

[12]  G. Rudenko,et al.  N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. , 1993, The Journal of biological chemistry.

[13]  V. Lingappa,et al.  Evidence for an alternate model of human P-glycoprotein structure and biogenesis. , 1993, The Journal of biological chemistry.

[14]  D. Clarke,et al.  Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein. , 1993, The Journal of biological chemistry.

[15]  T. Tsuruo,et al.  Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. , 1993, The Journal of biological chemistry.

[16]  G. Ames,et al.  The ATP-binding component of a prokaryotic traffic ATPase is exposed to the periplasmic (external) surface. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Tsui,et al.  The spectrum of cystic fibrosis mutations. , 1992, Trends in genetics : TIG.

[18]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.

[19]  G. Rummel,et al.  Crystal structures explain functional properties of two E. coli porins , 1992, Nature.

[20]  L. Tisa,et al.  Membrane topology of the ArsB protein, the membrane subunit of an anion-translocating ATPase. , 1992, The Journal of biological chemistry.

[21]  S. Devine,et al.  Amino acid substitutions in the sixth transmembrane domain of P-glycoprotein alter multidrug resistance. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Valverde,et al.  Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein , 1992, Nature.

[23]  G. Ames,et al.  Topology of the hydrophobic membrane-bound components of the histidine periplasmic permease. Comparison with other members of the family. , 1992, The Journal of biological chemistry.

[24]  M. P. Gallagher,et al.  Membrane topology of the integral membrane components, OppB and OppC, of the oligopeptide permease of Salmonella typhimurium , 1992, Molecular microbiology.

[25]  G. Schulz,et al.  Molecular architecture and electrostatic properties of a bacterial porin. , 1991, Science.

[26]  V. Ling,et al.  Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation. , 1991, The Journal of biological chemistry.

[27]  P. Gros,et al.  A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Borst,et al.  Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. , 1991, Cancer research.

[29]  G. Schulz,et al.  The structure of porin from Rhodobacter capsulatus at 1.8 Å resolution , 1991, FEBS letters.

[30]  S. Séror,et al.  Analysis of the membrane organization of an Escherichia coli protein translocator, HlyB, a member of a large family of prokaryote and eukaryote surface transport proteins. , 1991, Journal of molecular biology.

[31]  S. Beck,et al.  Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.

[32]  R. Demars,et al.  A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway , 1990, Nature.

[33]  C. Manoil,et al.  lac permease of Escherichia coli: topology and sequence elements promoting membrane insertion. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Henderson,et al.  Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.

[35]  H. Khorana,et al.  Transmembrane protein structure: spin labeling of bacteriorhodopsin mutants. , 1990, Science.

[36]  P. Gros,et al.  Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities , 1990, Molecular and cellular biology.

[37]  S. Akiyama,et al.  Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. , 1989, The Journal of biological chemistry.

[38]  I. Pastan,et al.  Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine. , 1989, The Journal of biological chemistry.

[39]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[40]  A. Safa,et al.  Photoaffinity labeling of P-glycoprotein in multidrug resistant cells with photoactive analogs of colchicine. , 1989, Biochemical and biophysical research communications.

[41]  A. Varshavsky,et al.  The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein , 1989, Nature.

[42]  A. Cowman,et al.  Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum , 1989, Cell.

[43]  P. Gros,et al.  Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA. , 1989, Cancer research.

[44]  I. Pastan,et al.  The multidrug transporter, a double-edged sword. , 1988, The Journal of biological chemistry.

[45]  D. Housman,et al.  Cloning and characterization of a second member of the mouse mdr gene family , 1988, Molecular and cellular biology.

[46]  S. Silver,et al.  Nucleotide sequence of the structural genes for an anion pump. The plasmid-encoded arsenical resistance operon. , 1986, The Journal of biological chemistry.

[47]  D. Housman,et al.  Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins , 1986, Cell.

[48]  Michael M. Gottesman,et al.  Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells , 1986, Cell.

[49]  I. Pastan,et al.  Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Safa,et al.  Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. , 1986, The Journal of biological chemistry.

[51]  J. Deisenhofer,et al.  Structure of the protein subunits in the photosynthetic reaction centre of Rhodopseudomonas viridis at 3Å resolution , 1985, Nature.

[52]  R. Welch,et al.  Nucleotide sequence of an Escherichia coli chromosomal hemolysin , 1985, Journal of bacteriology.

[53]  G. Cox,et al.  Phosphate-specific transport system of Escherichia coli: nucleotide sequence and gene-polypeptide relationships , 1985, Journal of bacteriology.

[54]  D. Eisenberg,et al.  Analysis of membrane and surface protein sequences with the hydrophobic moment plot. , 1984, Journal of molecular biology.

[55]  R. Lerner,et al.  Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[56]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[57]  J. Pollard,et al.  Characterization of cell lines showing growth control isolated from both the wild type and a leucyl‐tRNA synthetase mutant of chinese hamster ovary cells , 1979, Journal of cellular physiology.

[58]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Henderson,et al.  Three-dimensional model of purple membrane obtained by electron microscopy , 1975, Nature.

[60]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[61]  R. Arceci,et al.  The multidrug resistance (mdr1) gene product functions as an ATP channel. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[62]  H. Kaback,et al.  [33] Preparation of monoclonal antibodies and site-directed polyclonal antibodies against the lac permease of Escherichia coli , 1986 .

[63]  V. Ling,et al.  Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies , 1985, Nature.